What should I do if I become resistant to Sacituzumab govitecan?

Sacituzumab govitecan is a drug used to treat certain types of cancer, specifically metastatic triple-negative breast cancer and metastatic urothelial cancer. However, if a patient develops resistance to gosatuzumab, some steps may need to be taken to modify the treatment regimen.

A detailed discussion with your doctor is first recommended. They will assess the patient's condition and may recommend further testing to determine the cause of resistance. This can include molecular testing, tumor genetic sequencing, or other related tests. Depending on the patient's specific circumstances, your doctor may consider changes in chemotherapy regimens, combination therapies, clinical trials, etc. to develop the most appropriate treatment plan. Resistance may occur in response to changing drugs or the order of drugs; combination therapy refers to the simultaneous use of several different drugs to improve the effectiveness of treatment, such as targeted therapy drugs, immunotherapy or other treatments. If other treatment options are limited, your doctor may recommend participating in a clinical trial. Since everyone's constitution is different, their resistance to drugs is also different. If drug resistance occurs after using the drug, please inform your doctor in time and do not adjust the drug dosage yourself.

Gosatuzumab The original drug has been launched in China, but it has not yet been included in the medical insurance. The price of a 100mg bottle may be around 10,000 yuan, which is relatively expensive. Gosatuzumab Original drug marketed overseas has three versions: European version, American version, and Singapore version. SpecificationsThe price of each 100 mg bottle may be around RMB 10,000-35,000 (the price may fluctuate due to exchange rates). The ingredients of gosatuzumab sold domestically and abroad are basically the same. There is currently no generic version of gosatuzumab available on the market. For specific prices and drug information, please consult your medical consultant.